1st US-Japan Biostatistics Workshop - Final Program -
date：SEPTEMBER 26, 2003
place：Translational Research Informatics Center
1-5-4 Minatojima Minami-machi, Chuo-ku, Kobe 650-8543, Japan
10:00
・
Opening Remarks
Masanori Fukushima, M.D., Ph.D.
Professor, Translational Research Center
Kyoto University Hospital
Session I
Innovative Design and Analysis in Cancer Clinical Trials
10:20-12:20
1）
Session Chairperson
Hideki Origasa, Ph. D.
Professor, Biostatistics
Toyama Medical and Pharmaceutical University
10:20
2）
CRM (Continual Reassessment Method)
Naoki Ishizuka, Ph. D.
Biostatistician, Data Center
Japan Clinical Oncology Group
11:00
3）
Recent Attempts and Experiences in Design of Cancer Clinical Trials
Yasuo Ohashi, Ph. D.
Professor, Biostatistics/Epidemiology and Preventive Health Sciences
University of Tokyo
Chairman, Japan Clinical Research Support Unit
11:40
4）
Some Design Issues in Cancer Clinical Trials
John J. Crowley, Ph.D.
Director, Statistical Center
Southwest Oncology Group
12:20 Lunch
Session II
Statistical Analysis on Integrating Gene Expression Profiling into Clinical Trials
13:20-15:20
1）
Session Chairperson
Shigeyuki Matsui, Ph. D.
Associate Professor, Pharmacoepidemiology
Kyoto University
13:20
2）
Prognostic Prediction using DNA Microarray Gene Expression Data
Shigeyuki Matsui, Ph. D.
14:00
3）
Correlation of Gene Expression Profiles with Survival Times
Donna K. Pauler, Ph.D.
Biostatistician, Statistical Center
Southwest Oncology Group
14:40
4）
Gene Exploration and Correlation: Applications to Lymphoma
Michael LeBlanc, Ph.D.
Biostatistician, Statistical Center
Southwest Oncology Group
15:20 Break
Session III
Statistical Issues in Analysis and Interpretation of Clinical Studies
15:50-17:20
1）
Session Chairperson
Masayuki Imamura, M.D., Ph.D.
Professor, Surgery and Surgical Basic Science
Kyoto University
Toshihiko Morikawa, Ph. D.
General Manager, CDM and Biostatistics
Takeda Chemical Industries, Ltd.
15:50
2）
Interpretation of Clinical Trials from the Perspective of Clinicians
Shunzo Maetani, M.D., Ph.D.
Director, Statistical Analysis Group
Tenri Institute of Medical Research
16:20
3）
Development and Evaluation of Measurement Methods for Clinical Trials
Eisei Oda, Ph.D.
Biostatistician
Translational Research Informatics Center
16:50
4）
Individual Patient-Level and Study-Level Meta-Analysis for Investigating Modifiers of Treatment Effect
Satoshi Teramukai, Ph.D.
Assistant Professor, Translational Research Center
Kyoto University Hospital
17:20
5）
Final Remarks
Kiyoyuki Furuse, M.D.
Director
The Japan Multinational Trial Organization
